Recently, cancer prevention research reports have shown that chemopreventive agents, such as curcumin, EGCG (epigallocatechin gallate), and resveratrol, have the therapeutic potential to sensitize prostate cancer cells to TRAIL [36-38]. This evidence concerns the gene TNFSF10 and Familial prostate cancer.